Home / Pharmaceuticals / Erectile Dysfunction Treatment Drugs Market By Drug Type (Phosphodiesterase Type 5 Inhibitors (Pde5 Inhibitors), Prostaglandin E1) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

Erectile Dysfunction Treatment Drugs Market By Drug Type (Phosphodiesterase Type 5 Inhibitors (Pde5 Inhibitors), Prostaglandin E1) - Growth, Future Prospects And Competitive Analysis, 2017 - 2025

Published: Nov 2017 | Report Code: 58829-11-17

Erectile dysfunction is a very common sexual problem affecting 100 million people worldwide. It is often contributed by neurological disorders, cardiovascular diseases, diabetes, hormonal imbalance and obesity. The incidence of erectile dysfunction is also proportionate to ageing, along with being associated with certain risk factors such as usage of tobacco and alcohol, certain medications and medical treatment, injuries and psychological conditions.

Globally increasing prevalence of chronic ailments, especially diabetes and cardiovascular diseases and sedentary lifestyle are anticipated to fuel the growth of erectile dysfunction treatment drugs market. Market penetration of local players manufacturing generic drugs also contributes growth to the erectile dysfunction treatment drugs market.  However, the erectile dysfunction treatment drugs market is expected to decline due to the patent expiration of the commercially available branded drugs. Social stigma about sexual issues among public in developing countries poses a challenge on the overall growth of the market. Growing trend of alternative therapies like natural medicine, surgery and other medical device might hinder the growth of erectile dysfunction treatment drugs market. Pipeline drugs under clinical trials are projected to emerge as growth opportunity of erectile dysfunction treatment drugs market in future years.

The scope of this research study entitled ‘Erectile Dysfunction Treatment Drugs Market - Growth, Future Prospects, and Competitive Analysis, 2017 – 2025’ is to provide company executives, developers, investors, and industry participants with actionable information with in-depth analysis to take tactical decisions and strategic initiatives associated to the projections in the global erectile dysfunction treatment drugs market. Major developments and trends prevailing in the global erectile dysfunction treatment drugs market and the market size and forecast are presented in the research report. Global health concern, increasing research initiatives to develop new products, rising demand among consumers and impressive pipeline product portfolio strongly boost up the growth of erectile dysfunction treatment drugs market.

This report contains the global erectile dysfunction treatment drugs market in terms of drugs type and geographical distribution. Based on the drug types, the erectile dysfunction treatment drugs market is segmented into Phosphodiesterase type 5 inhibitors (PDE5 inhibitors), Prostaglandin E1 and others. This report presents market size and forecast for every mentioned section for the period of 2015-2025 and their CAGRs for the forecast duration 2017-2025.

Geographically, the erectile dysfunction treatment drugs market is presented as five major regions which further are segmented as follow:

  • North America
    • The United States
    • Canada
  • Europe
    • The United Kingdom
    • Germany
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Latin America Middle East and Africa
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • Gulf Cooperation Council
    • Rest of Middle East and Africa

This report is comprised of data in order to determine market size with forecast of each geographical region for the years of 2015-2025 along with CAGRs for the forecast duration 2017-2025. Moreover, additional cross-sectional studies are presented in terms of type of drugs and constituent country/region level markets to gain a better insight.

This research report incorporates qualitative assessment components such as market dynamics to achieve an understanding of the current and future global market trends of erectile dysfunction treatment drugs market. Detailed description of competitive assessment tools such as partnerships and collaborations, major agreements, competitive landscape analysis, market attractiveness assessment by key players are mentioned in this report. Moreover, this research report includes profiling of major players in the erectile dysfunction treatment drugs market. The major players profiled in this report are Pfizer Inc., Dong-A Pharmaceutical Co. Ltd, Vivus, Inc., Meda Pharmaceuticals, Bayer AG, Johnson & Johnson Services, Apricus Biosciences, Eli Lilly and Company.

Erectile Dysfunction Treatment Drugs Market

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Erectile Dysfunction Treatment Drugs Market Portraiture
2.1.1. Global Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2016 (US$ Mn)
2.1.2. Global Erectile Dysfunction Treatment Drugs Market, by Geography, 2016 Vs. 2025 (Value %)

Chapter 3. Erectile Dysfunction Treatment Drugs: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. Erectile Dysfunction: Epidemiology
3.3. Erectile Dysfunction Treatment Drugs: Future Trends
3.4. Drivers
3.5. Challenges
3.6. Opportunities
3.7. Attractive Investment Proposition, by Geography, 2016
3.8. Major Agreements, Partnerships and Collaborations
3.9. Competitive Landscape
3.9.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Erectile Dysfunction Treatment Drugs Market, by Drug Type
4.2. Phosphodiesterase Type 5 Inhibitors (PDE5 Inhibitors)
4.2.1. Sildenafil (Viagra)
4.2.2. Tadalafil (Adcirca, Cialis)
4.2.3. Vardenafil (Levitra, Staxyn)
4.2.4. Avanafil (Stendra)
4.3. Prostaglandin E1
4.3.1. Alprostadil (Caverject, Edex, Muse, Prostin VR Pediatric)
4.4. Others

Chapter 5. Global Erectile Dysfunction Treatment Drugs Market: Pipeline Analysis
5.1. Overview
5.2. Phase III (Market estimations by 2025)
5.2.1. HCP 1302 (Hanmi Pharmaceutical)
5.3. Phase II (Qualitative Information)
5.4. Phase I (Qualitative Information)

Chapter 6. Global Erectile Dysfunction Treatment Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
6.1. Overview
6.2. North America Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.2.1. North America Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.2.2. North America Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.2.2.1. U.S.
6.2.2.2. Canada
6.3. Europe Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.3.1. Europe Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.3.2. Europe Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.3.2.1. U.K.
6.3.2.2. Germany
6.3.2.3. Rest of Europe
6.4. Asia Pacific Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.4.1. Asia Pacific Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.4.2. Asia Pacific Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.4.2.1. Japan
6.4.2.2. China
6.4.2.3. India
6.4.2.4. Rest of APAC
6.5. Latin America Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.5.1. Latin America Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.5.2. Latin America Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
6.5.2.1. Brazil
6.5.2.2. Mexico
6.5.2.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Erectile Dysfunction Treatment Drugs Market Analysis, 2015 – 2025
6.6.1. MEA Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
6.6.2. MEA Erectile Dysfunction Treatment Drugs Market, by Region, 2015 – 2025 (US$ Mn)
6.6.2.1. GCC
6.6.2.2. South Africa
6.6.2.3. Rest of MEA

Chapter 7. Company Profiles
7.1. Apricus Biosciences
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. Key Developments
7.2. Bayer AG
7.3. Dong-A Pharmaceutical Co. Ltd
7.4. Eli Lilly and Company
7.5. Johnson & Johnson Services
7.6. Meda Pharmaceuticals
7.7. Pfizer Inc.
7.8. Vivus, Inc.

List Of Table :

TABLE 1 Global Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Erectile Dysfunction Treatment Drugs Market, by Geography, 2015 – 2025 (US$ Mn)
TABLE 3 North America Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 4 North America Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 5 Europe Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 6 Europe Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 7 Asia Pacific Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 8 Asia Pacific Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Latin America Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 10 Latin America Erectile Dysfunction Treatment Drugs Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 11 Middle East And Africa Erectile Dysfunction Treatment Drugs Market, by Drug Type, 2015 – 2025 (US$ Mn)
TABLE 12 Middle East And Africa Erectile Dysfunction Treatment Drugs Market, by Region, 2015 – 2025 (US$ Mn)
TABLE 13 Apricus Biosciences: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 14 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 15 Dong-A Pharmaceutical Co. Ltd: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 16 Eli Lilly and Company: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 17 Johnson & Johnson Services: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 18 Meda Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 19 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 20 Vivus, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)

List Of Figures :

FIG. 1 Erectile Dysfunction Treatment Drugs: Market Segmentation
FIG. 2 Global Erectile Dysfunction Treatment Drugs Market Share, by Drug Type, 2016 (US$ Mn)
FIG. 3 Global Erectile Dysfunction Treatment Drugs Market, by Geography, 2016 Vs. 2025 (Value %)
FIG. 4 Attractive Investment Proposition, by Geography, 2016
FIG. 5 Market Competition Landscape, by Key Players, 2016
FIG. 6 Global Phosphodiesterase Type 5 Inhibitors (PDE5 Inhibitors) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 7 Global Sildenafil (Viagra) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 8 Global Tadalafil (Adcirca, Cialis) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 9 Global Vardenafil (Levitra, Staxyn) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 10 Global Avanafil (Stendra) Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 11 Global Prostaglandin E1 Market in Erectile Dysfunction Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 12 Global Alprostadil (Caverject, Edex, Muse, Prostin VR Pediatric) Market in Erectile Dysfunction
Treatment Drugs, 2015 – 2025 (US$ Mn)
FIG. 13 Global Others Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 14 U.S. Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 15 Canada Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 16 U.K. Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 17 Germany Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 18 Rest Of Europe Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 19 Japan Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 20 China Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 21 India Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest Of Asia Pacific Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 23 Brazil Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 24 Mexico Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest Of Latin America Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 26 GCC Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 27 South Africa Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)
FIG. 28 Rest Of Middle East And Africa Erectile Dysfunction Treatment Drugs Market, 2015 – 2025 (US$ Mn)

Based on the different types of drug used in order to treat erectile dysfunction, the erectile dysfunction treatment drugs market is categorized on the following basis:

  • Phosphodiesterase type 5 inhibitors (PDE5 Inhibitors)
    • Sildenafil (Viagra)
    • Tadalafil (Adcirca, Cialis)
    • Vardenafil (Levitra, Staxyn)
    • Avanafil (Stendra)
  • Prostaglandin E1
    • Alprostadil (Caverject, Edex, Muse, Prostin VR Pediatric)
  • Others

Phosphodiesterase type 5 inhibitors segment is estimated to be the leading in terms of revenue and better treatment outcomes in the erectile dysfunction treatment drugs market. PDE5 inhibitors are mostly preferred owing to easy administration, affordable cost and lowest risk caused by this class of drugs. Sildenafil, tadalafil and vardenafil act by relaxing blood vessel and improving blood circulation followed by sexual stimulation. Sidenafil is the most common and well known medication which has been used since very long time for its effective treatment of impotence. Minimal adverse effects, lower cost and simple administration of sidenafil drugs make this drug the most preferable among physicians which support the growth of erectile dysfunction treatment drugs market. Increasing popularity of tadalafil drugs due to its longer duration of function and improved erection rate also drives the erectile dysfunction market globally. However, due to higher cost and more side-effects, Avanafil is comparatively less popular than other PDE5 inhibitor drugs. Alprostadil drugs (prostaglandin E1 vasodilator) are used as either injectable form or as suppository, the former being lesser effective in treatment perspective.

Erectile Dysfunction Treatment Drugs Market

Geography wise, global erectile dysfunction treatment drugs market is cumulative to North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Erectile Dysfunction Treatment Drugs Market

North America is anticipated to dominate the erectile dysfunction treatment drugs market followed by Europe. According to the Massachusetts Male Aging Study, the prevalence of erectile dysfunction is around 52% which exhibited 30 million men in the United States have been suffering with various degrees of erectile impairments. Erectile dysfunction is more common in population older than age of 40; the growing ageing population and evolved public awareness have driven the market of erectile dysfunction treatment drugs. North America is expected to hold maximum market share due to presence of key erectile dysfunction treatment drugs manufacturers, growing demand for drugs, expanding production of generic drugs and increasing R&D expenditure for product development. Erectile dysfunction affects more than 20 million people in Europe. Existence of such huge population affected from erectile dysfunction, constantly rising prevalence of chronic diseases and competition among generic drug manufacturer for market share act as key driving factors for market growth in European region.

Asia Pacific is predicted to witness the fastest growth in future years on account of developing healthcare infrastructures, emerging personal income, and gradual growth in health awareness among public; whereas Middle East and Africa is expected to exhibit steady and constant market growth.

The detailed regional classification of the global erectile dysfunction treatment drugs market is as follows:

  • North America (Canada and the United States)
  • Europe (The United Kingdom, Germany, and rest of European countries)
  • Asia Pacific (China, India, Japan and rest of Asia -Pacific countries)
  • Latin America (Brazil, Mexico, and rest of LATAM countries)
  • Middle East and Africa (GCC, South Africa and rest of MEA countries)
Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients